Analysis of Risk Factors of Lung Cancer Patients Combined with Sarcopenia and Their Correlation with Clinical Prognosis
1.Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,China
2.Key Laboratory of Respiratory Diseases Research and Medical Transformation of Anhui Province,Hefei 230022,China
*Corresponding author:FEI Guanghe,Chief physician,Professor,Doctoral supervisor;E-mail:guanghefei@126.com
LI Zhouhua,JI Shuang,HU Xianwei, et al. Analysis of Risk Factors of Lung Cancer Patients Combined with Sarcopenia and Their Correlation with Clinical Prognosis [J]. Chinese General Practice, 2021, 24(26): 3310-3315. DOI: 10.12114/j.issn.1007-9572.2021.00.599.
李周华,季爽,胡先纬等. 肺癌患者并发肌肉减少症的危险因素分析及其与临床预后的相关性探讨[J]. 中国全科医学, 2021, 24(26): 3310-3315. DOI: 10.12114/j.issn.1007-9572.2021.00.599.
[1]JAIN R,COSS C,WHOOLEY P,et al.The role of malnutrition and muscle wasting in advanced lung cancer[J].Curr Oncol Rep,2020,22(6):54.DOI:10.1007/s11912-020-00916-9.
[2]BARACOS V E,REIMAN T,MOURTZAKIS M,et al.Body composition in patients with non-small cell lung cancer:a contemporary view of cancer cachexia with the use of computed tomography image analysis[J].Am J Clin Nutr,2010,91(4):1133S-1137S.DOI:10.3945/ajcn.2010.28608C.
[3]NAKAMURA R,INAGE Y,TOBITA R,et al.Sarcopenia in resected NSCLC:effect on postoperative outcomes[J].J Thorac Oncol,2018,13(7):895-903.DOI:10.1016/j.jtho.2018.04.035.
[4]WILLIAMS G R,RIER H N,MCDONALD A,et al.Sarcopenia & aging in cancer[J].J Geriatr Oncol,2019,10(3):374-377.DOI:10.1016/j.jgo.2018.10.009.
[5]CHEN L,LIU L,WOO J,et al.Sarcopenia in Asia:consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.DOI:10.1016/j.jamda.2013.11.025.
[6]BUENTZEL J,HEINZ J,BLECKMANN A,et al.Sarcopenia as prognostic factor in lung cancer patients:a systematic review and meta-analysis[J].Anticancer Res,2019,39(9):4603-4612.DOI:10.21873/anticanres.13640.
[7]CHOI S,RYU E. Effects of symptom clusters and depression on the quality of life in patients with advanced lung cancer[J].Eur J Cancer Care(Engl),2018,27(1).DOI:10.1111/ecc.12508.
[8]CHANG K V,HSU T H,WU W T,et al.Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies[J].Age Ageing,2017,46(5):738-746.DOI:10.1093/ageing/afx094.
[9]JANG R W,CARAISCOS V B,SWAMI N,et al. Simple prognostic model for patients with advanced cancer based on performance status[J].J Oncol Pract,2014,10(5):e335-341. DOI:10.1200/JOP.2014.001457.
[10]CHARLSON M E,POMPEI P,ALES K L,et al. A new method of classifying prognostic comorbidity in longitudinal studies:development and validation[J].J Chronic Dis,1987,40(5):373-383. DOI:10.1016/0021-9681(87)90171-8.
[11]KONDRUP J,ALLISON S P,ELIA M,et al.ESPEN guidelines for nutrition screening 2002[J].Clin Nutr,2003,22(4):415-421.DOI:10.1016/s0261-5614(03)00098-0.
[12]GEERSE O P,HOEKSTRA-WEEBERS J E H M,STOKROOS M H,et al.Structural distress screening and supportive care for patients with lung cancer on systemic therapy:a randomised controlled trial[J].Eur J Cancer,2017,72:37-45.DOI:10.1016/j.ejca.2016.11.006.
[13]HECHTNER M,EICHLER M,WEHLER B,et al.Quality of life in NSCLC survivors — a multicenter cross-sectional study[J].J Thorac Oncol,2019,14(3):420-435.DOI:10.1016/j.jtho.2018.11.019.
[14]ROSENBERG I H. Summary comment[J].Am J Clin Nutr,1989,50(l):1231S-1233S.DOI:10.1093/ajcn/50.5.1231.
[15]CRUZ-JENTOFT A J,LANDI F,TOPINKOVá E,et al.Understanding sarcopenia as a geriatric syndrome[J].Curr Opin Clin Nutr Metab Care,2010,13(1):1-7.DOI:10.1097/MCO.0b013e328333c1c1.
[16]ROM O,KAISARI S,AIZENBUD D,et al.Sarcopenia and smoking:a possible cellular model of cigarette smoke effects on muscle protein breakdown[J].Ann N Y Acad Sci,2012,1259:47-53.DOI:10.1111/j.1749-6632.2012.06532.x.
[17]PADDON-JONES D,SHEFFIELD-MOORE M,CREE M G,
et al.Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress[J].J Clin Endocrinol Metab,2006,91(12):4836-4841.DOI:10.1210/jc.2006-0651.
[18]TRESTINI I,GKOUNTAKOS A,CARBOGNIN L,et al.Muscle derangement and alteration of the nutritional machinery in NSCLC[J].Crit Rev Oncol Hematol,2019,141:43-53.DOI:10.1016/j.critrevonc.2019.06.007.
[19]SIEBER C C. Malnutrition and sarcopenia[J].Aging Clin Exp Res,2019,31(6):793-798.DOI:10.1007/s40520-019-01170-1.
[20]MARTONE A M,BIANCHI L,ABETE P,et al.The incidence of sarcopenia among hospitalized older patients:results from the Glisten study[J].J Cachexia Sarcopenia Muscle,2017,8(6):907-914.DOI:10.1002/jcsm.12224.
[21]MARCASON W. Should albumin and prealbumin be used as indicators for malnutrition?[J].J Acad Nutr Diet,2017,117(7):1144.DOI:10.1016/j.jand.2017.04.018.
[22]JANG M K,PARK C,HONG S,et al.Skeletal muscle mass change during chemotherapy:a systematic review and meta-analysis[J].Anticancer Res,2020,40(5):2409-2418.DOI:10.21873/anticanres.14210.
[23]HILMI M,JOUINOT A,BURNS R,et al.Body composition and sarcopenia:the next-generation of personalized oncology and pharmacology? [J].Pharmacol Ther,2019,196:135-159.DOI:10.1016/j.pharmthera.2018.12.003.
[24]WANG H,HAI S,LIU Y X,et al.Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals[J].Clin Interv Aging,2018,13:1605-1611.DOI:10.2147/CIA.S173146.
[25]DY S M,LORENZ K A,NAEIM A,et al.Evidence-based recommendations for cancer fatigue,anorexia,depression,and dyspnea[J].J Clin Oncol,2008,26(23):3886-3895.DOI:10.1200/JCO.2007.15.9525.
[26]KUPFERBERG A,BICKS L,HASLER G. Social functioning in major depressive disorder[J].Neurosci Biobehav Rev,2016,69:313-332.DOI:10.1016/j.neubiorev.2016.07.002.
[27]NO?L P H,WILLIAMS J J W,UNüTZER J,et al.Depression and comorbid illness in elderly primary care patients:impact on multiple domains of health status and well-being[J].Ann Fam Med,2004,2(6):555-562.DOI:10.1370/afm.143.
[28]RYAN A M,PRADO C M,SULLIVAN E S,et al.Effects of weight loss and sarcopenia on response to chemotherapy,quality of life,and survival[J].Nutrition,2019,67-68:110539.DOI:10.1016/j.nut.2019.06.020.
[29]VERLAAN S,ASPRAY T J,BAUER J M,et al.Nutritional status,body composition,and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults:a case-control study[J].Clin Nutr,2017,36(1):267-274.DOI:10.1016/j.clnu.2015.11.013.
[30]KEOGH J W L,MACLEOD R D. Body composition,physical fitness,functional performance,quality of life,and fatigue benefits of exercise for prostate cancer patients:a systematic review[J].J Pain Symptom Manage,2012,43(1):96-110.DOI:10.1016/j.jpainsymman.2011.03.006.
[31]KILGOUR R D,VIGANO A,TRUTSCHNIGG B,et al.Cancer-related fatigue:the impact of skeletal muscle mass and strength in patients with advanced cancer[J].J Cachexia Sarcopenia Muscle,2010,1(2):177-185.DOI:10.1007/s13539-010-0016-0.
[32]AULINO P,BERARDI E,CARDILLO V M,et al.Molecular,cellular and physiological characterization of the cancer Cachexia-inducing C26 colon carcinoma in mouse[J].BMC Cancer,2010,10:363.DOI:10.1186/1471-2407-10-363.